UNLOCKD Reports 76% Month-Over-Month Revenue Growth at Ancient Extracts Following Acquisition

BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD Inc. ("UNLOCKD"), reported encouraging early operating results for its recently acquired subsidiary, VerdaGenix LLC d/b/a Ancient Extracts USA ("Ancient Extracts"). The company disclosed preliminary May 2026 revenue of approximately $22,344, representing a 76% month-over-month increase from April's preliminary revenue of $12,670. Management noted that operations under UNLOCKD ownership commenced in mid-May following the acquisition closing, meaning the reported May revenue reflects only a partial month of ownership.

Additionally, on June 2, 2026, Ancient Extracts received a purchase order representing approximately $58,823 in retail product value, with an order total of approximately $29,411 under wholesale pricing terms. These figures are preliminary, unaudited, and subject to further review. John P. Gorst, CEO of UNLOCKD, stated, "We remain in the early stages of integrating Ancient Extracts into the UNLOCKD organization, but we are encouraged by the commercial momentum we are seeing. The combination of accelerating revenue, customer demand, and expanding distribution opportunities reinforces our belief that Ancient Extracts possesses many of the qualities that originally attracted us to this acquisition."

Ancient Extracts offers a portfolio of functional mushroom products, ceremonial teas, cacao blends, matcha, shilajit, and wellness-focused consumer goods under the brand philosophy of "Ancient Remedies for Modern Life." The company believes it is well positioned to capitalize on growing consumer interest in functional mushrooms, adaptogens, and botanical wellness products. Dr. Jordan P. Balencic, Chairman and Chief Science Officer of UNLOCKD, commented, "When we evaluated Ancient Extracts, we believed the business possessed a number of attractive characteristics, including a differentiated product portfolio, a loyal customer base, a capital-efficient operating model, and multiple pathways for future growth. While it remains early in the integration process, the initial operating results and commercial traction we are seeing continue to reinforce our conviction in the opportunity."

Separately, UNLOCKD's Technologies division has initiated preliminary planning for future consumer health technology opportunities, including early-stage evaluation of point-of-care testing concepts and discussions with developers, suppliers, and potential partners. These initiatives remain conceptual, and the company expects to pursue dedicated financing for any future technology development rather than diverting capital from current operations. Dr. Balencic added, "Our objective is straightforward: grow revenue, expand distribution, strengthen our portfolio of wellness assets, and execute with discipline. We believe Ancient Extracts provides a strong operating nucleus capable of supporting broader growth initiatives across wellness, functional nutrition, cognitive health, and human optimization."

For more information, visit www.unlockdinc.com and follow @BFCHco on X for verified company updates. This press release contains forward-looking statements subject to risks and uncertainties, and the company undertakes no obligation to update such statements except as required by law.